Metraipolis › archive › dc_221fd25b7ec8
[Prognostic value of circulating plasma cell in newly diagnosed multiple myeloma treated with bortezomib, lenalidomide, and dexamethasone] — Europe PMC PMID:41145287
- Source
- Europe PMC (chi)
- Original
- https://europepmc.org/article/MED/41145287
- DOI
- 10.3760/cma.j.cn121090-20241209-00549
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T05:36:10.989Z
- SHA-256 of the archived text
232b6973f54a5b55f26447138795b329916e49da5baa09c0220b4a00fb24ff14- Stable URL of this page
https://metraipolis.com/documento/dc_221fd25b7ec8
How to cite
[Prognostic value of circulating plasma cell in newly diagnosed multiple myeloma treated with bortezomib, lenalidomide, and dexamethasone] — Europe PMC PMID:41145287 — Europe PMC (chi), https://europepmc.org/article/MED/41145287 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_221fd25b7ec8 (Metraipolis archive dc_221fd25b7ec8, sha256 232b6973f54a5b55f26447138795b329916e49da5baa09c0220b4a00fb24ff14)
BibTeX
@misc{dc221fd25b7ec8,
title = {[Prognostic value of circulating plasma cell in newly diagnosed multiple myeloma treated with bortezomib, lenalidomide, and dexamethasone] — Europe PMC PMID:41145287},
howpublished = {Europe PMC (chi)},
url = {https://europepmc.org/article/MED/41145287},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_221fd25b7ec8; sha256 232b6973f54a5b55f26447138795b329916e49da5baa09c0220b4a00fb24ff14},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41145287. Agents can read the archived copy with the MCP tool read_document.